Internal Medicine, Hematology · Salt Lake City, UT
NPI
1427008341
Since 2006
Specialty
Internal Medicine, Hematology
Code 207RH0000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
1950 Circle of Hope Dr
Salt Lake City, UT, 84112
Phone (801) 585-0100
Groups this clinician bills Medicare through
Medicare paid, 2024
$15K
279 services
Medicare patients, 2024
55
Average age 72
Drug cost, 2024
$4.6M
533 prescriptions
Company payments, 2025
$4,760
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Josef T Prchal was code 99214 (office e&m - established), 108 times for 48 patients. In total Josef T Prchal billed 279 services in 9 codes, and Medicare paid $15K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-12-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 108 | 48 | $68.84 | $7,435 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 74 | 39 | $12.70 | $940 |
| 99214 Office E&M - Established | Office | 28 | 15 | $98.92 | $2,770 |
| 99215 Office E&M - Established | Facility | 22 | 17 | $86.75 | $1,908 |
By year: 2022 $13K for 167 services; 2023 $12K for 154 services; 2024 $15K for 279 services.
Medicare prescription drug claims, 2024
In 2024, the drug Josef T Prchal prescribed most often to Medicare patients was Besremi (Ropeginterferon Alfa-2b-Njft), with 176 prescriptions and refills. In total Josef T Prchal wrote 533 Medicare prescriptions that cost $4.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Besremi Ropeginterferon Alfa-2b-Njft | 176 | 180 | 28 | $2.7M |
| Hydroxyurea Generic | 70 | 114 | 20 | $1,843 |
| Droxia Hydroxyurea | 37 | 59 | 13 | $1,262 |
| Acyclovir Generic | 37 | 47 | Under 11 | $525 |
| Anagrelide Hcl Generic | 37 | 38 | Under 11 | $2,939 |
| Jakafi Ruxolitinib Phosphate | 36 | 36 | Under 11 | $602K |
| Ojjaara Momelotinib Dihydrochloride | 26 | 26 | Under 11 | $692K |
| Allopurinol Generic | 17 | 17 | Under 11 | $77.26 |
| Pyrukynd Mitapivat Sulfate | 11 | 11 | Under 11 | $292K |
Brand drugs: 320 claims; generic drugs: - claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Josef T Prchal $4,760 ($4,760 in general payments such as food, travel and fees) from 4 companies. The largest payer was Takeda Pharmaceuticals U.S.A., Inc. with $4,489.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.